CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-14 | Ross Thomas W. Sr. Director | Purchase | +5,000 | $14.73 | $74K | 26,822 |
| 2016-12-12 | Pershing Square Capital Management, L.P. Director | Sale | −3,476,690 | $14.85 | $51.6M | 18,114,432 |
| 2016-12-12 | Pershing Square Capital Management, L.P. Director | Purchase · Call Option (put equivalent position) | +9,120,000 | $0.01 | $91K | 0 |
| 2016-12-05 | Whitaker Anne Clem EVP, Company Group Chairman | Shares withheld for taxes | −6,012 | $18.00 | $108K | 158,544 |
| 2016-12-05 | Rosiello Robert L. EVP, Corp Dev & Strategy | Shares withheld for taxes | −14,687 | $18.00 | $264K | 517,683 |
| 2016-12-05 | Whitaker Anne Clem EVP, Company Group Chairman | Shares withheld for taxes | −6,505 | $18.00 | $117K | 158,885 |
| 2016-12-05 | Kellen Ari EVP, Company Group Chairman | Shares withheld for taxes | −19,932 | $18.00 | $359K | 630,842 |
| 2016-11-04 | Rosiello Robert L. EVP, Corp Dev & Strategy | Shares withheld for taxes | −817 | $22.06 | $18K | 532,370 |
| 2016-09-30 | INGRAM ROBERT ALEXANDER Director | Grant or award | +865 | $24.55 | $21K | 88,463 |
| 2016-09-30 | ROBERTSON RUSSEL C Director | Grant or award | +1,376 | $24.55 | $34K | 18,414 |
| 2016-09-30 | WECHSLER AMY B Director | Grant or award | +1,018 | $24.55 | $25K | 17,969 |
| 2016-08-22 | Herendeen Paul EVP, Chief Financial Officer | Grant or award | +150,000 | 150,000 | ||
| 2016-08-22 | Herendeen Paul EVP, Chief Financial Officer | Grant or award · Non-Qualified Stock Options (right to purchase) | +1,000,000 | 1,000,000 | ||
| 2016-08-11 | KARABELAS ARGERIS N Director | Purchase | +4,000 | $24.65 | $99K | 20,726 |
| 2016-08-10 | ACKERMANN CHRISTINA EVP and General Counsel | Grant or award · Non-Qualified Stock Options (right to purchase) | +39,469 | 39,469 | ||
| 2016-08-08 | ACKERMANN CHRISTINA EVP and General Counsel | Grant or award | +122,762 | 122,762 | ||
| 2016-08-03 | Rosiello Robert L. EVP, Chief Financial Officer | Shares withheld for taxes | −1,338 | $23.54 | $31K | 533,187 |
| 2016-08-02 | Whitaker Anne Clem EVP, Company Group Chairman | Shares withheld for taxes | −834 | $23.54 | $20K | 158,544 |
| 2016-07-27 | KAVANAGH SARAH B Director | Grant or award | +14,458 | 14,458 | ||
| 2016-07-01 | ESHELMAN FREDRIC N Director | Shares withheld for taxes | −26 | $23.78 | $618 | 17,796 |
Page 41 of 43 · 851 trades